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Abstract: Biological damage mediated by
reactive oxygen species has been increasingly
recognized in aging phenomena in recent
decades. The increase in catecholamine
metabolism is yet another physiological
change in aging, predisposing the organism
to supranormal hydrogen peroxide production as a by-product. This study was undertaken to investigate the alterations in oxidant-antioxidant status in rat cardiac tissue
during aging. The effects of acute administration of monoamine oxidase (MAO)
inhibitors on this status were also investigated to find possible preventive strategies in
conjugate aging. MAO activities, malondialdehyde MDA and diene conjugate levels as well
as superoxide dismutase and catalase activities were determined in the cardiac tissues of
young and aging groups, each consisting of
10 rats. MAO inhibitors (deprenyl and pargyline) were administered to another two
groups of young and aging animals (10 in
each group) and the same parameters were
also determined in these groups. Cardiac tissue MAO activities (p<0.005) as well as diene
conjugates (p<0.0001) and MDA levels
(p<0.005) were found to be significantly
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Introduction
As the elderly population increases due to the
advances in the modern world, a knowledge of the
physiology and fundamental causes of aging, in particular,
the role of reactive oxygen species (ROS) therein, is a
prerequisite in understanding geriatric problems. The intr
intricate causes of the aging process are still a matter of
extensive speculation giving rise to many theories (1, 2).
Biological damage mediated by ROS has increasingly
come to be recognized in recent decades as an important
factor in human disease, ranging from inflammatory
conditions to cancer. ROS, generated continuously in the

higher in aging compared to young control
groups. The increases in these parameters
were all correlated. Acute MAO inhibitor
administration caused significant decreases in
MAO activities in both young (p<0.0005 with
deprenyl and p<0.0001 with pargyline) and
aging groups (p<0.0001 with deprenyl and
p<0.00001 with pargyline). Parallel to this
finding, diene conjugate and MDA levels were
also found to be decreased after MAO administration. Although the aging control group
had manifested a decrease in antioxidant
enzymes; SOD and catalase (p<0.05, both),
acute administration of MAO inhibitors did
not induce any significant changes in these
parameters. In conclusion, our experimental
data suggest that catecholamine metabolism
and MAO activity may play a role in the
pathological alterations in the aging cardiac
tissue by serving as an important source for
increased lipid peroxidation, and inhibition of
this activity may play a role in limiting the
clinical sequelae of these alterations.
Key Words: Monoamine oxidase inhibitors,
lipid peroxidation, antioxidant enzymes, cardiac tissue, aging.

cells either as accidental by-products of metabolism or
deliberately during the presence of phagocytosis, ionizing
radiation, drugs capable of redox cycling, or
metabolization of xenobiotics are also considered to be
critical factors involved in aging processes (3, 4, 5).
Cells have developed a comprehensive array of
antioxidant defences to limit the formation or deleterious
effects of ROS. Among these are enzymes that
decompose peroxides, proteins that sequester transition
metals and a range of compounds that scavenge free
radicals (4, 5).
The increases in catecholamine metabolism have also
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received attention among the physiological changes in
aging, and monamine oxidase (EC 1.4.3.4; amine: oxygen
oxidoreductase (deaminating) (flavin containing) (MAO), a
key enzyme in this process, has recently been studied
extensively (6). MAO catalyzes the oxidative deamination
of amines according to the overall reaction, as shown
below:
Monoamine oxidase
RCH2NH2 + O2 + H2O ———–—→ RCHO + NH3 + H2O2
Hydrogen peroxide (H2O2), the readily diffusable byproduct of MAO activity, is an example of ROS which can
cross cell membranes, causing damage at sites distant
from its area of generation. This molecule, although not
a free radical, falls into the category of ROS and can act
as either a destructive species by itself or as an
intermediate in the production of the hydroxyl radical
(OH• ). Recent studies have shown that H2O2 is an
important mediator of cardiac ischemia-reperfusion injury
causing perturbations in cardiomyocyte carbohydrate
metabolism and heart-muscle energy balance (7).
MAO inhibitors (mainly deprenyl) have been widely
used in depression and Parkinson’s disease due to their
effects on catecholamine metabolism. These agents have
been shown to reduce the catabolism of dopamine, exert
an endogenous amphetamine-like tonic effect and, most
importantly, suppress the generation of endogenous
neurotoxic free radicals (8).
Based on the fact that free radicals and their effects
(mainly lipid peroxidation) might have significant roles in
the aging organism, this study was undertaken first to
examine the role of oxidative stress and antioxidant
enzymes with regard to the increased MAO activity in the
aging rat heart. Since MAO activity is a possible source of
H2O2, the second aim of the study was to investigate the
variations in the related parameters induced by the acute
administration of MAO inhibitors.
Materials and Methods

Chemicals
All chemicals were analytical grade. EDTA,
kynuramine, thiobarbituric acid, epinephrine, and bovine
erythrocyte SOD standard and bovine serum albumin
standard were purchased from Sigma. While cyclohexan
was obtained from Riedel de Haen, all the rest of the
chemicals (saccharose, KH2PO4, Na2HPO4, K2HPO4, 4Hydroxyquinoline, NaOH, TCA, chloroform, methanol,
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Na2CO3, NaHCO3, hydrogen peroxide, Na-K tartarate,
CuSO4, and the reactives of Folin-chiocalteu) were
purchased from Merck & Darmstadt Co.
MAO inhibitors, Deprenyl (selegiline) was purchased
from Kocak Drug Company (Turkey), while pargyline was
purchased from Sigma.

Animals
Eight groups of male Swiss Albino rats were formed,
as shown in Table 1.

Preparation of the heart tissue
The animals were decapitated and their hearts quickly
excised and washed thoroughly in cold (4˚C) saline. The
heart tissue was minced to three fractions; while a
homogenate for MAO activity was prepared with
EDTA/saccharose (1/10, w/v), a homogenate with
phosphate buffer (KH2PO4, Na2HPO4.2 H2O, 50 mM,
pH=7.0) (1/10, w/v) was prepared for diene conjugates,
SOD and catalase determinations. For MDA analysis, the
last fraction of the tissue was homogenized in distilled
water (2/1, w/v) and later with TCA, 5%. Supernatants
were obtained from all homogenates, after being
centrifuged at 1500 g for 10 minutes. All procedures
were conducted on ice, analysis being performed on the
same day.

Methods
MAO activity was determined fluorometrically (by
Aminco-Bowman spectrofluorometer) by the modified
method of Kraml (9), results being given as nmol/mg
prot/hr.
For the determinations of the diene conjugates,
Bueger’s spectrometric method was used (10), results
being given as nmol hydroperoxide/mg protein.
MDA determinations were conducted by Slater and
Sawyer’s modification of the MDA-TBA test (11)
originally proposed by Yagi, the concentration of MDA (in
nmol/gr. tissue) being calculated using an extinction
coefficient of 153 000/Mol/cm.
SOD and catalase activities were determined by the
methods of Misra of Fridovich (12) anal Aebit Luck (13)
respectively, the results being given as U/mg protein.
Protein determinations were performed by the
method of Lowry (14).

Statistical analysis
Statistical analysis was performed by MICROSTA and
ANOVA programs. For comparison of the means, the
student’s t test was used, and for intergroup
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Physiologic young group

n=10

2-3 months
(150-200 gr)

no agent was given

Physiologic aging group

n=10

16-18 months
(250-300 gr)

no agent was given

Young placebo group

n=10

2-3 months
(150-200 gr)

2.5 cc isotonic saline given
intraperitoneally 1 1/2 hours
before decapitation

Aging placebo group

n=10

16-18 months
(250-300 gr)

2.5 cc isotonic saline given
intraperitoneally 1 1/2 hours
before decapitation

Young deprenyl group

n=10

2-3 months
(150-200 gr)

25 mg/kg deprenyl dissolved in
2.5 cc isotonic saline given
intraperitoneally 1 1/2 hours
before decapitation

Aging deprenyl group

n=10

16-18 months
(250-300 gr)

25 mg/kg deprenyl dissolved in
2.5 cc isotonic saline given
intraperitoneally 1 1/2 hours
before decapitation

Young pargyline group

n=10

2-3 months
(150-200 gr)

25 mg/kg pargyline dissolved in
2.5 cc isotonic saline given
intraperitoneally 1 1/2 hours
before decapitation

Aging pargyline group

n=10

16-18 months
(250-300 gr)

25 mg/kg pargyline dissolved in
2.5 cc isotonic saline given
intraperitoneally 1 1/12 hours
before decapitation

comparisons, analysis of variance was used, followed by
the Newman Keuls multiple. The correlations between the
parameters were determined by paired correlation tests.
Results
In comparison to young control tissue, aging cardiac
tissue showed significant increases (p<0.005) in MAO
enzyme activities. Acute administration of MAO inhibitors
caused a significant reduction in these activities in both
the young (p<0.0005 with deprenyl and p<0.0001 with
pargyline) and aging (p<0.0001 with deprenyl and
p<0.00001 with pargyline) groups. The overall findings
for MAO enzyme activities are presented in Table 2.
In the second phase of the study where lipid
peroxidation parameters were investigated, a significantly

Table 1.

The characteristics and treatment protocols of the experimental groups.

higher increase was observed in the aging group
(p<0.0001 for diene conjugates and p<0.005 for MDA)
than in the young control group (Table 3).
When the correlation between lipid peroxidation and
MAO activities was investigated, it was found that MDA
showed a significant correlation (r=0.9358) with MAO in
the aging control group. Similarly, the correlation
between diene conjugates and MAO was also significant
(r=0.9668) in this group.
The administration of acute doses of deprenyl resulted
in significant decreases in diene conjugates and MDA
levels (p<0.005 in both young and aging groups as
compared to controls); however, a more significant
reduction in the MDA levels of the aging group
(p<0.0005 in both) was detected with pargyline. These
decreases in MDA and diene conjugate levels after
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Groups

MAO

SD

p

p<0.005

Table 2.

Cardiac tissue MAO activities
of all groups.

Table 3.

Diene conjugate and MDA
levels of all groups.

(nmol/mg
protein)

Physiologic control

Placebo control

Deprenyl

Pargyline

Young

n=10

53.35

20.35

Aging

n=10

76.19

12.93

Young

n=10

55.72

18.56

Aging

n=10

72.96

13.05

Young

n=10

21.54

4.94

p<0.0005

Aging

n=10

21.61

3.86

p<0.0001

Young

n=10

18.12

6.35

p<0.0001

Aging

n=10

23.31

4.96

p<0.00001

Groups

MDA*

SD

Diene

p<0.005

SD

Conj.**
Physiologic control
Placebo Control
Deprenyl
Pargyline

Young

n=10

5.35

1.53

31.98

4.20

Aging

n=10

20.72

6.92

46.56

17.93

Young

n=10

5.17

1.65

30.96

5.46

Aging

n=10

18.97

5.43

32.76

6.53

Young

n=10

3.72

0.57

25.19

5.70

Aging

n=10

11.86

3.74

25.47

6.74

Young

n=10

3.65

0.87

24.97

2.47

Aging

n=10

10.32

2.68

25.96

6.97

*MDA expressed in nmol/g tissue.
**Diene conjugates expressed in nmol/mg protein.

administration of MAO inhibitors correlated with the
decreases in MAO levels, as examplified in Figures 1 and
2.
As to antioxidant enzyme activities, SOD and catalase
activities showed a decrease (p<0.05) in the aging group
as compared to the young controls. Administration of
MAO inhibitors induced only statistically insignificant
increases in these antioxidant enzymes.
Discussion
This study provides evidence of increased cardiac
tissue MAO activities in the aging organism, parallel to the
increases observed in MDA and diene conjugates, which
are reliable lipid peroxidation parameters. Inhibition of
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the MAO activity in rat cardiac tissue by acute
administration of MAO inhibitors not only limited the
activity of this enzyme, but also the increase in oxidative
stress. These results confirm the role of MAO activity as
an important source in the free radical theory of aging.
Recently, pathological alterations in the cardiac
function of the aging organism have received much
attention, and these changes have been partly ascribed to
the presence of increased ROS. Reduced effectiveness of
β adrenergic stimulation in relaxing vascular muscle leads
to increased ischemia-reperfusion periods and oxidant
stress in cardiac tissue, the overall effects being reflected
in sarcolemmal and mitochondrial membrane changes,
alterations in carbohydrate metabolism and myofibrillary
creatine kinase activity. These effects could explain the
development of heart dysfunction, which seems to be an
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y= 1,01x + 3,2635
r= 0.8828
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Figure 1.

The correlation between MAO and diene conjugates in
young groups given deprenyl.

inevitable progressive change in physiological aging (15,
16).
Since lipid peroxidation is one of the most important
organic expressions of oxidative stress induced by ROS,
various analytic methods have been tried in recent
decades. Of these, MDA and diene conjugates appear to
be reliable markers. The peroxidation of polyunsaturated
fatty acids (PUFAs) is the major source in MDA formation,
since MDA is formed during the last stages of the
breakdown of endoperoxides (17). Conjugated dienes, on
the other hand, are other lipid peroxidation markers
which form a sort of transition state between lipid
radicals and peroxy radicals.
The possible sources of free radicals in cardiac tissue
are xanthine oxidase, mitochondrial respiration,
metabolism of arachidonic acid and invading leucocytes,
as well as catecholamine oxidation. Of these, one
enzymatic reaction that may be enhanced in cardiac tissue
upon aging is the deamination of catecholamines
catalyzed by MAO. In the aging organism, the increased
catecholamine availability during ischemia-reperfusion
and the subsequent hyperoxia may lead to supranormal
hydrogen peroxide production. MAO activity becomes
oxygen-dependent during ischemia when catecholamine
concentrations increase. Thus, when oxygen is
reintroduced on reperfusion, a burst of H2O2 production
may occur.
Increased H2O2 production and the accompanying
oxidative stress could have various pathological changes
in the cardiac tissue, and H2O2 may produce cellular
damage directly or indirectly. Direct damage may result
from inactivation of enzymes (ATP synthetase

Figure 2.

The correlation between MAO and diene conjugates in the
aging group given pargyline.

mitochondrial way and glyceraldehyde 3 phosphate
dehydrogenase glycolytic way) or the oxidation of NADH
or sulfhydryl groups. On the other hand, H2O2 also can
exert cytotoxicity indirectly via formation of the highly
reactive OH• catalyzed by transition metals (7, 18, 19). In
periods of increased oxidative stress, ATP reduction,
functional deterioration, lipid peroxidation and
myocardial tissue damage finally results. The injury
potential of H2O2 -induced oxidative stress on heart
muscle carbohydrate metabolism has been shown. H2O2
may also disturb heart muscle energy balance. It must
also be stressed that H2O2 is an important mediator of the
tissue injury associated with myocardial ischemiareperfusion (9).
MAO, as a source of H2O2 was evaluated during
ischemia-reperfusion in vivo in the rat brain by Simonson
et al. who have concluded that MAO is an important
source of H2O2 generation early in brain reperfusion (18).
Going one step further, Zhang and Piantadosi have shown
that inhibition of MAO with pargyline protected rats from
convulsions and led to decreased H2O2 production in the
brain (20).
Although our current work does not directly
investigate H2O2 levels which would be the by-product of
MAO metabolism, lipid peroxidation parameters were
determined to prove the increase in oxidant stress. Our
results, which manifested increased MAO activity with
correlated increases in lipid peroxidation in the aging rat
heart, support the hypothesis that catecholamine
oxidation is an important source of increased oxidant
stress. The aging organism also manifested lower levels
of antioxidant capacity, another altered metabolism that
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aids in the manifestation of oxidative stress. Although the
acute administration of MAO inhibitors caused a reduction
in MAO activities in heart tissue, which paralleled the
reduction in lipid peroxidation parameters, no significant
change in antioxidant status was determined. This
observation was attributed to the acute administration of
the agents. Long-term administration of the MAO
inhibitors and its effects on oxidant and antioxidant status
is still a challenging area of investigation in which our
current work is now being carried out.
Elucidating the presence and nature of the aging
process in the cardiovascular system is a formidable task.
By this study, it has been shown that aging rat heart

tissue has increased MAO activity, which might be a
crucial source of the increased lipid peroxidation and
oxidative stress. Inhibiton of MAO activity in the rat
cardiac tissue has proved to be a way of decreasing the
supranormal oxidative stress in the aging organism and
perhaps exerting protective effects on survival. In
conclusion, our experimental data suggests that
catecholamine metabolism and MAO activity may play a
role in the pathological alterations in aging rat cardiac
tissue, and that inhibition of this activity may have a role
in limiting the clinical sequelae of these alterations.
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